Long COVID & ME: Genetics, Tests, GLP-1s and other Drugs | Steve Gardner
The session recording is not yet available.
Video on Demand
Get access to 100 conference recordings. Choose the access option that fits you: patients, early-career researchers, professionals and industry. Watch the sessions that matter most to you, whenever it suits you.
Thu 27 Aug
15:18
10 min
Abstract #116
Church Hall
Clinical Track
Long COVID & ME: Genetics, Tests, GLP-1s and other Drugs
This presentation explores the shared genetic and biological mechanisms underlying Long COVID and ME/CFS using advanced genomic and artificial intelligence approaches. The study identifies common disease pathways, potential biomarkers, and promising therapeutic targets, supporting the development of precision medicine and personalized treatment strategies for post-infectious illnesses.
Steve Gardner | CEO – Chair Data AI and Genomics Advisory Board – Scientific Advisory Board member
PrecisionLife, BioIndustry Association (BIA), Our Future Health UK, Oxford, United Kingdom
Presentation slides are not yet available.